skip to Main Content

The BEMER® therapy is designed to support the body’s fundamental physiological processes, thereby promoting the improvement of natural self-regulatory mechanisms and offers the following scientifically proven effects: positive effects on microcirculation , the immune System, the protein biosynthesis and the formation of free radical scavengers that have been naturally produced by the body.

Therefore, the BEMER therapy already offers a wide range of application possibilities with very good supportive effects in the areas of therapy, regeneration, rehabilitation and prevention.

BEMER can be used as an important complementary therapy option for physicians/therapists and is not intended to replace other medical treatments.

How it Works

By means of a weak, pulsating and special multidimensional signal configuration of generated electromagnetic fields, BEMER devices are suitable for stimulating vasomotion (rhythmic contractions) of the smaller and smallest blood vessels in living organisms.

Through certain biorhythmic modulations, somewhat larger blood vessels upstream and downstream are also synergistically influences. This results in more favourable microcirculatory blood flow for the treated organisms. The results are improved functionally of natural regulatory mechanisms, strengthening of the immune system, improved production of the body’s own radical scavengers and an influence on the protein synthesis. The BEMER technology can be used for the prevention and complementary treatment of diseases, leading to an improvement in microcirculation and resulting in a definite therapeutic effect in living organisms.


The BEMER therapy is indicated for the prevention and complementary therapy of diseases and conditions which are caused, accompanied or complicated by impaired microcirculation due to a decreased vasomotion.

EXEMPLES for such diseases and conditions are:

  • Chronic wound healing disorders
  • Chronic degenerative diseases of the musculoskeletal system
  • Chronic metabolic disorders (e.g. diabetes mellitus; lipid metabolism disorders)
  • Organ insufficiencies (e.g. liver dysfunction, multiple organ dysfunction)
  • Polyneuropathies caused by diabetes mellitus or following oncological interventions
  • Peripheral arterial occlusion disease
  • Chronic fatigue (e.g., in patients with chronic stress or with sclerosis multiplex)
  • Acute and chronic pain syndrome
  • Reduced quality of life conditions
Back To Top